Thomas Ruhstaller

Thomas Ruhstaller

UNVERIFIED PROFILE

Are you Thomas Ruhstaller?   Register this Author

Register author
Thomas Ruhstaller

Thomas Ruhstaller

Publications by authors named "Thomas Ruhstaller"

Are you Thomas Ruhstaller?   Register this Author

47Publications

1063Reads

-Profile Views

Reply to K.-D. Yu et al.

J Clin Oncol 2019 Apr 29:JCO1900325. Epub 2019 Apr 29.

Thomas Ruhstaller, MD, Kantonsspital St Gallen, St Gallen, Universitatsspital Basel, Basel, and International Breast Cancer Study Group, Bern, Switzerland; and Meredith M. Regan, ScD, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA and International Breast Cancer Study Group, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.00325DOI Listing
April 2019

Vitamin D levels in Swiss breast cancer survivors.

Swiss Med Wkly 2018 16;148:w14576. Epub 2018 Jan 16.

Breast Centre St Gallen, St Gallen Cantonal Hospital, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4414/smw.2018.14576DOI Listing
September 2018

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.

N Engl J Med 2018 Jul 4;379(2):122-137. Epub 2018 Jun 4.

From the Peter MacCallum Cancer Centre, St. Vincent's Hospital, University of Melbourne, Melbourne, VIC, and Breast Cancer Trials Australia and New Zealand, University of Newcastle, Newcastle, NSW (P.A.F.), and the University of Sydney, Sydney (A.S.C.) - all in Australia; the Institute of Oncology of Southern Switzerland, Ospedale San Giovanni, Bellinzona (O.P.), Breast Cancer St. Gallen, St. Gallen (T.R.), and the International Breast Cancer Study Group Coordinating Center (R.M., M.R.-P., B.R., A.S.C.), University Hospital Inselspital (M.R.-P.), Bern - all in Switzerland; the University of Chicago Medical Center, Chicago (G.F.F.); the University of Calgary, Calgary, AB, Canada (B.A.W.); the Division of Medical Senology, European Institute of Oncology (M.C.), and the European Institute of Oncology and International Breast Cancer Study Group (A.G.), Milan, Ospedale Papa Giovanni XXIII, Bergamo (C.T.), Azienda Socio Sanitaria Territoriale Sette Laghi-Ospedale di Circolo and Fondazione Macchi, Varese (G.P.), Medical Oncology and Cancer Prevention, IRCCS, National Cancer Institute, Aviano (F.P., S.S.), the Department of Medicine, School of Medical Oncology, University of Udine, Udine (F.P.), Salvatore Maugeri Foundation, Pavia (L.P.), and the Hospital of Prato-Azienda Unità Sanitaria Locale Toscana Centro, Prato (A.D.L.) - all in Italy; the National Institute of Oncology, Budapest, Hungary (I.L.); Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru (H.L.G.); University Hospital 12 de Octubre, Madrid (E.C.), Vall d'Hebron Institute of Oncology and Vall d'Hebron University Hospital, Barcelona (M.B.), and Instituto Valenciano de Oncologia, Valencia (M.A.C.) - all in Spain; the Susan F. Smith Center for Women's Cancers (H.J.B., E.P.W.) and the International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology (R.D.G., M.M.R.), Dana-Farber Cancer Institute, Harvard Medical School, the Harvard T.H. Chan School of Public Health, and Frontier Science and Technology Research Foundation (R.D.G.) - all in Boston; Institut Bergonié Comprehensive Cancer Center, Université de Bordeaux, Bordeaux, France (H.R.B., M.D.); the Angeles Clinic and Research Institute, Santa Monica, CA (S.M.); Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond (C.E.G.); Mayo Clinic, Rochester, MN (M.P.G., J.N.I.); Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore (V.S.); Fred Hutchinson Cancer Research Center, University of Washington, Seattle (N.E.D.); Weston Park Hospital, Sheffield, United Kingdom (R.C.); and the Department of Obstetrics and Gynecology, University Medical Center, Regensburg, Germany (S.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1803164DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193457PMC
July 2018

Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial.

J Clin Oncol 2016 05 28;34(14):1601-10. Epub 2016 Mar 28.

Karin Ribi, Aron Goldhirsch, and Jürg Bernhard, International Breast Cancer Study Group Coordinating Center; Jürg Bernhard, Bern University Hospital, Inselspital, Bern; Thomas Ruhstaller, Breast Center St Gallen, Swiss Group for Clinical Cancer Research, and International Breast Cancer Study Group, St Gallen, Switzerland; Weixiu Luo, Karen N. Price, Richard D. Gelber, and Meredith M. Regan, International Breast Cancer Study Group Statistical Center; Weixiu Luo, Harold J. Burstein, Richard D. Gelber, and Meredith M. Regan, Dana-Farber Cancer Institute; Harold J. Burstein, Alliance for Clinical Trials in Oncology; Karen N. Price and Richard D. Gelber, Frontier Science and Technology Research Foundation; Richard D. Gelber and Meredith M. Regan, Harvard Medical School, Boston, MA; Gini F. Fleming, The University of Chicago Medical Center and Alliance for Clinical Trials in Oncology, Chicago, IL; Prudence A. Francis, International Breast Cancer Study Group, Peter MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne, Victoria; Australia and New Zealand Breast Cancer Trials Group, University of Newcastle, Newcastle; Alan S. Coates, International Breast Cancer Study Group and University of Sydney, Sydney, New South Wales, Australia; Eva Ciruelos, University Hospital 12 de Octubre and SOLTI Group, Madrid; Meritxell Bellet, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, and SOLTI Group, Universitat Autònoma de Barcelona, Barcelona; Ana Lluch, Hospital Clinico Universitario de Valencia, Incliva Biomedical Research Institute, University of Valencia and SOLTI Group, Valencia; Antonia Perelló, Hospital Universitari Son Espases and SOLTI Group, Palma de Mallorca, Spain; Lorenzo Pavesi, Salvatore Maugeri Foundation and International Breast Cancer Study Group, Pavia; Marilena Visini, Ospedale Civile di Lecco and International Breast Cancer Study Group, Lecco; Carlo Tondini, Ospedale Papa Giovanni XXIII and International Brea

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.8675DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872319PMC
May 2016

Cervical and vaginal cancer in a woman with chronic graft-versus-host disease.

Int J Gynaecol Obstet 2011 Aug 12;114(2):159-60. Epub 2011 Jun 12.

Department of Obstetrics and Gynecology, Cantonal Hospital of St Gallen, St Gallen, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijgo.2011.02.018DOI Listing
August 2011

Heated (37 degrees C) oxaliplatin infusion in combination with capecitabine for metastatic colorectal carcinoma: can it reduce neuropathy?

Support Care Cancer 2010 Oct 12;18(10):1263-70. Epub 2009 Sep 12.

Medical Oncology, Kantonsspital Graubünden, Chur, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-009-0740-1DOI Listing
October 2010

Fatal herpes simplex virus hepatitis in a patient with esophageal cancer under radiochemotherapy.

Onkologie 2008 Nov 27;31(11):620-2. Epub 2008 Oct 27.

Abteilung Onkologie/Hamatologie, Departement Innere Medizin, Kantonsspital Graubunden, Chur, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000162283DOI Listing
November 2008

The multidisciplinary meeting: An indispensable aid to communication between different specialities.

Eur J Cancer 2006 Oct 28;42(15):2459-62. Epub 2006 Aug 28.

Division of Oncology-Haematology, Kantonsspital St. Gallen, Rorschacherstr. 107, CH-9007, Switzerland; Department of Clinical Oncology, Cumberland Infirmary, Carlisle CA2 7HY, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2006.03.034DOI Listing
October 2006

CASE 3. Red eye in Sjogren's syndrome due to underlying mucosa-associated lymphoid tissue lymphoma.

J Clin Oncol 2006 Feb;24(6):1011-3

Medizinische Onkologie/Hämatologie, Departement Innere Medizin, and Institut für Radiologie, Kantonsspital, St Gallen, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.01.1544DOI Listing
February 2006

Resection of skin metastases from gastric carcinoma with long-term follow-up: an unusual clinical presentation.

Onkologie 2005 Jan;28(1):38-40

Abteilung für Onkologie/Hämatologie, Gallen, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000082266DOI Listing
January 2005